Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal Cancer

Published:2017 Issue:5 Volume:93 Page:329-335
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Komori Azusa,Taniguchi Hiroya,Hamauchi Satoshi,Masuishi Toshiki,Kito Yosuke,Narita Yukiya,Tsushima Takahiro,Ishihara Makoto,Todaka Akiko,Tanaka Tsutomu,Yokota Tomoya,Kadowaki Shigenori,Machida Nozomu,Ura Takashi,Fukutomi Akira,Ando Masashi,Onozawa Yusuke,Tajika Masahiro,Yasui Hirofumi,Muro Kei,Mori Keita,Yamazaki Kentaro

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of curcumin on the biological behavior of colorectal cancer cells through the JAK/STAT3 and RAS/MAPK/NF-κB pathways;Investigación Clínica;2022-11-11

2. Regorafenib in metastatic colorectal cancer: more data for clinical decisions;Journal of Modern Oncology;2021-11-19

3. Serum macrophage inhibitory cytokine-1 serves as a novel diagnostic biomarker of early-stage colorectal cancer;Biomarkers;2021-07-19

4. Clinical Value of Serum CEA, CA24-2 and CA19-9 in Patients with Colorectal Cancer;Clinical Laboratory;2021

5. Apatinib Monotherapy for Chemotherapy-Refractory Metastatic Colorectal Cancer: A Multi-centre, Single-Arm, Prospective Study;Scientific Reports;2020-04-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP